Results 111 to 120 of about 21,166 (196)

Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience

Cancer Management and Research, 2019
Yu-dong Xiao, Cong Ma, Zi-shu Zhang,* Jun Liu* Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China *These authors contributed equally to this work Objective: To evaluate the feasibility and ...
Xiao YD, Ma C, Zhang ZS, Liu J
doaj  

Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new era

Journal for ImmunoTherapy of Cancer
Anti-programed cell death protein-1 (PD-1) and anti-programmed cell death 1 ligand 1 (PD-L1) antibodies combined with anti-vascular endothelial growth factor (VEGF) or anti-cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies are now standard therapeutic
Aruj Dhyani, James J Harding
doaj   +1 more source

Effect of Noise Management in Interventional Radiology Suites on Patients Undergoing Transarterial Chemoembolization: A Retrospective Study

Noise and Health
Objective: This study aims to evaluate the effect of noise management in interventional radiology suites on patients undergoing transarterial chemoembolization (TACE). Methods: A retrospective cohort study design was employed.
Yong Lu, Lingyu Ma, Zhuo Chen, Hui Qi, Zhaotian Gu, Lei Wu, Benfang Fan   +6 more
doaj   +1 more source

A preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma [PDF]

, 2015
published_or_final_versio
Chow, KM, Chu, AC, Law, WL, Ng, L, Pang, RWC, Poon, RTP, Yau, TCC   +6 more
core  

A comparison of the therapeutic efficacy of transarterial chemoembolization and combination therapy with transarterial chemoembolization plus sorafenib for unresectable hepatocellular carcinoma

A comparison of the therapeutic efficacy of transarterial chemoembolization and combination therapy with transarterial chemoembolization plus sorafenib for unresectable hepatocellular carcinoma
[Background and Aims] The combination therapy of transarterial chemoembolization (TACE) plus sorafenib has been applied for unresectable hepatocellular carcinoma (HCC). However, its efficacy remains controversial, possibly due to the timing of the initiation of sorafenib treatment.
openaire   +1 more source

Synchronous <i>vs</i> sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. [PDF]

World J Gastrointest Surg
Yu Y, Yuan W, Lei J, Zhao CB, Tao CG, Liu SH, Wang BL.   +6 more
europepmc   +1 more source

Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion. [PDF]

J Hepatocell Carcinoma
Zeng J, Huang H, Tang M, Tao Z, Mo K, Chen W, Su Y, Su J, Liang R, Lin Y, Li L, Wu G, Luo X, Ye J, Mai R.   +14 more
europepmc   +1 more source

Comparison of the Efficacy and Safety of Transarterial-Chemoembolization versus Radiofrequency-Ablation for Hepatocellular Carcinoma within Milan Criteria: A Propensity Score-Matching Study. [PDF]

J Hepatocell Carcinoma
Tang W, Huang Y, Wang T, Yang J, Zhao Z.
europepmc   +1 more source

Neoadjuvant TACE combined with chemo-immunotherapy for giant triple-negative breast cancer: a case report. [PDF]

Front Immunol
Tan J, Li Z, Li ZJ, Kang FL, Xiang H, Yan P.   +5 more
europepmc   +1 more source

Transarterial Infusion of Pembrolizumab Plus TACE for Liver Metastases of Melanoma. [PDF]

Cancer Rep (Hoboken)
Akhlaghpoor S, Rouientan H.
europepmc   +1 more source